Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Cantor Fitzgerald
Johnson and Johnson

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,614,557

« Back to Dashboard

Title: Method of controlling tumor growth rate
Abstract:.alpha.-Fluoromethyl- or .alpha.-difluoromethylornithine, and certain derivatives thereof, can be used alone or in combination with cytotoxic agents for the treatment of neoplastic diseases.
Inventor(s): Bey; Philippe (Strasbourg, FR), Jung; Michel (Graffenstaden, FR)
Assignee: Marion Merrell et Compagnie C/O Merrell Pharmaceuticals Inc. (Cincinnati, OH)
Filing Date:Mar 14, 1995
Application Number:08/403,531
Claims:1. A method of controlling tumor growth susceptible to treatment with the combination below in a patient in need thereof comprising concomitantly administering to said patient an effective anti-tumor amount of methylglyoxal bis(guanylhydrazone) and an effective polyamine biosynthesis inhibitory amount of .alpha.-difluoromethyl ornithine or a pharmaceutically acceptable salt thereof.

2. A process of claim 1 wherein the tumor to be treated is lymphoma.

3. A process of claim 1 wherein the tumor to be treated is Hodgkins Disease.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
US Army
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.